Polyion Complex Comprising PHD2 Expression Inhibiting Substance
Disclosed is a safer and more sustainable gene delivery system or the like, which is effective for treatment of ischemic diseases and the like. Specifically disclosed is a pharmaceutical composition which contains, as an active ingredient, a polyanionic substance that inhibits the expression of PHD2, and which contains a polyion complex of the polyanionic substance and a polycationically charged polymer.
JP 2,011,026,219 [MORE INFO
KATAOKA KAZUNORI [JP]; WU SHOURONG [JP]; NISHIYAMA NOBUHIRO [JP]; ITAKA KEIJI [JP]; KOYAMA HIROYUKI [JP]; HASHIMOTO TAKUYA [JP];
Type of Offer:
« More Material Science Patents« More Medical Patents